NEW YORK, June 6 (GenomeWeb News) - Shares in Ciphergen Biosystems were up 15 percent, or $.17, at $1.29 in mid-day trading today after the company yesterday presented favorable results from a study evaluating the use of its biomarkers to detect ovarian cancer.

 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers have sequenced the northern white rhinoceros to gauge whether it could be brought back from the edge of extinction, the New York Times reports.

Bavaria expands its forensic genetic analyses to include DNA phenotyping, raising discrimination concerns.

Tufts University researchers found a role for miRNA in transmitting stress between generations, the Economist reports.

In Science this week: gut microbiome influences liver cancer growth, spread; and more.